Cargando…

Diosgenin Prevents Microglial Activation and Protects Dopaminergic Neurons from Lipopolysaccharide-Induced Neural Damage In Vitro and In Vivo

Background: The prevention of age-related neurodegenerative disorders is an important issue in an aging society. Microglia-mediated neuroinflammation resulting in dopaminergic neuron loss may lead to the pathogenesis of Parkinson’s disease (PD). Lipopolysaccharide (LPS), an endotoxin, induces neuroi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lee, Shou-Lun, Tu, Ssu-Chieh, Hsu, Ming-Yen, Chin, Ting-Yu
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8508726/ https://www.ncbi.nlm.nih.gov/pubmed/34638697 http://dx.doi.org/10.3390/ijms221910361

Ejemplares similares

Erinacine A Prevents Lipopolysaccharide-Mediated Glial Cell Activation to Protect Dopaminergic Neurons against Inflammatory Factor-Induced Cell Death In Vitro and In Vivo
por: Lee, Shou-Lun, et al.
Publicado: (2022)

In Vivo Protective Effects of Diosgenin against Doxorubicin-Induced Cardiotoxicity
por: Chen, Chih-Tai, et al.
Publicado: (2015)

DJ-1 inhibits microglial activation and protects dopaminergic neurons in vitro and in vivo through interacting with microglial p65
por: Lin, Zixuan, et al.
Publicado: (2021)

Licochalcone A Prevents the Loss of Dopaminergic Neurons by Inhibiting Microglial Activation in Lipopolysaccharide (LPS)-Induced Parkinson’s Disease Models
por: Huang, Bingxu, et al.
Publicado: (2017)

Auraptene and Other Prenyloxyphenylpropanoids Suppress Microglial Activation and Dopaminergic Neuronal Cell Death in a Lipopolysaccharide-Induced Model of Parkinson’s Disease
por: Okuyama, Satoshi, et al.
Publicado: (2016)

Tiagabine Protects Dopaminergic Neurons against Neurotoxins by Inhibiting Microglial Activation
por: Liu, Jie, et al.
Publicado: (2015)

Diosgenin hemihydrate
por: Hernández Linares, María-Guadalupe, et al.
Publicado: (2012)

ROCK/Cdc42-mediated microglial motility and gliapse formation lead to phagocytosis of degenerating dopaminergic neurons in vivo
por: Barcia, Carlos, et al.
Publicado: (2012)

The Equilibria of Diosgenin–Phosphatidylcholine and Diosgenin–Cholesterol in Monolayers at the Air/Water Interface
por: Janicka, Katarzyna, et al.
Publicado: (2016)

Ganoderma lucidum Protects Dopaminergic Neuron Degeneration through Inhibition of Microglial Activation
por: Zhang, Ruiping, et al.
Publicado: (2011)

Clozapine metabolites protect dopaminergic neurons through inhibition of microglial NADPH oxidase
por: Jiang, Lulu, et al.
Publicado: (2016)

Cytokine Profiling in Human iPSC-Derived Dopaminergic Neuronal and Microglial Cultures
por: Knappe, Evelyn, et al.
Publicado: (2023)

Alkaloids from piper longum protect dopaminergic neurons against inflammation-mediated damage induced by intranigral injection of lipopolysaccharide
por: He, Huan, et al.
Publicado: (2016)

Purple Sweet Potato Leaf Extract Induces Apoptosis and Reduces Inflammatory Adipokine Expression in 3T3-L1 Differentiated Adipocytes
por: Lee, Shou-Lun, et al.
Publicado: (2015)

Down-regulation of microglial activity attenuates axotomized nigral dopaminergic neuronal cell loss
por: Song, Dae-Yong, et al.
Publicado: (2013)

Tubeimoside I Protects Dopaminergic Neurons Against Inflammation-Mediated Damage in Lipopolysaccharide (LPS)-Evoked Model of Parkinson’s Disease in Rats
por: He, Dewei, et al.
Publicado: (2018)

Identification of a specific α-synuclein peptide (α-Syn 29-40) capable of eliciting microglial superoxide production to damage dopaminergic neurons
por: Wang, Shijun, et al.
Publicado: (2016)

Oxytocin inhibits lipopolysaccharide-induced inflammation in microglial cells and attenuates microglial activation in lipopolysaccharide-treated mice
por: Yuan, Lin, et al.
Publicado: (2016)

JNK-mediated microglial DICER degradation potentiates inflammatory responses to induce dopaminergic neuron loss
por: Wang, Qing, et al.
Publicado: (2018)

Inhibition of Nigral Microglial Activation Reduces Age-Related Loss of Dopaminergic Neurons and Motor Deficits
por: Wang, Tzu-Feng, et al.
Publicado: (2022)

Beneficial effect of diosgenin as a stimulator of NGF on the brain with neuronal damage induced by Aβ-42 accumulation and neurotoxicant injection
por: Koh, Eun-Kyoung, et al.
Publicado: (2016)

Modulation of M1/M2 polarization by capsaicin contributes to the survival of dopaminergic neurons in the lipopolysaccharide-lesioned substantia nigra in vivo
por: Bok, Eugene, et al.
Publicado: (2018)

Disruption of Fractalkine Signaling Leads to Microglial Activation and Neuronal Damage in the Diabetic Retina
por: Cardona, Sandra M., et al.
Publicado: (2015)

DAP12 and CD11b contribute to the microglial-induced death of dopaminergic neurons in vitro but not in vivo in the MPTP mouse model of Parkinson’s disease
por: Kinugawa, Kiyoka, et al.
Publicado: (2013)

Tp53 gene mediates distinct dopaminergic neuronal damage in different dopaminergic neurotoxicant models
por: Lu, Tao, et al.
Publicado: (2017)

trans-Cinnamaldehyde Inhibits Microglial Activation and Improves Neuronal Survival against Neuroinflammation in BV2 Microglial Cells with Lipopolysaccharide Stimulation
por: Fu, Yan, et al.
Publicado: (2017)

Olfactory Sensory Activity Modulates Microglial-Neuronal Interactions during Dopaminergic Cell Loss in the Olfactory Bulb
por: Grier, Bryce D., et al.
Publicado: (2016)

An update on the biological and pharmacological activities of diosgenin
por: Kim, Jae Kwang, et al.
Publicado: (2018)

HOTTIP downregulation reduces neuronal damage and microglial activation in Parkinson's disease cell and mouse models
por: Lun, Peng, et al.
Publicado: (2021)

In vivo and in vitro Development of Human Mesencephalic Dopaminergic Neurons
por: Silani, Vincenzo, et al.
Publicado: (1992)

Synergistic effects of lipopolysaccharide and rotenone on dopamine neuronal damage in rats
por: He, Jing‐Yi, et al.
Publicado: (2023)

Microglial Activation Damages Dopaminergic Neurons through MMP-2/-9-Mediated Increase of Blood-Brain Barrier Permeability in a Parkinson’s Disease Mouse Model
por: Ruan, Zhengzheng, et al.
Publicado: (2022)

Microglial Ultrastructure in the Hippocampus of a Lipopolysaccharide-Induced Sickness Mouse Model
por: Savage, Julie C., et al.
Publicado: (2019)

Complementary neural correlates of motivation in dopaminergic and noradrenergic neurons of monkeys
por: Bouret, Sebastien, et al.
Publicado: (2012)

P7C3 Inhibits LPS-Induced Microglial Activation to Protect Dopaminergic Neurons Against Inflammatory Factor-Induced Cell Death in vitro and in vivo
por: Gu, Chao, et al.
Publicado: (2018)

Diosgenin: Recent Highlights on Pharmacology and Analytical Methodology
por: Jesus, Mafalda, et al.
Publicado: (2016)

Inhibition of invadopodia formation by diosgenin in tumor cells
por: Lian, Yaxin, et al.
Publicado: (2020)

The origin and evolution of the diosgenin biosynthetic pathway in yam
por: Cheng, Jian, et al.
Publicado: (2020)

Diosgenin: An Updated Pharmacological Review and Therapeutic Perspectives
por: Semwal, Prabhakar, et al.
Publicado: (2022)

Anticancer Activity of Diosgenin and Its Molecular Mechanism
por: Ren, Qun-li, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_0ctu5nfmo2eaustg5013crsl14